<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0008">
 <label>8.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Zhu</surname>
   <given-names>FC</given-names>
  </string-name>, 
  <string-name>
   <surname>Wurie</surname>
   <given-names>AH</given-names>
  </string-name>, 
  <string-name>
   <surname>Hou</surname>
   <given-names>LH</given-names>
  </string-name>, et al. 
  <article-title>Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, Phase 2 trial</article-title>. 
  <source>
   <italic toggle="yes">Lancet</italic>
  </source>. 
  <year>2017</year>;
  <volume>389</volume>(
  <issue>10069</issue>):
  <fpage>621</fpage>â€“
  <lpage>628</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/S0140-6736(16)32617-4</pub-id>
  <pub-id pub-id-type="pmid">28017399</pub-id>
 </mixed-citation>
</ref>
